Targeted-release budesonide therapy for IgA nephropathy - Authors' reply.

Fellström, Bengt; Barratt, Jonathan; Flöge, Jürgen; Jardine, Alan

Fellström, Bengt; Barratt, Jonathan; Flöge, Jürgen; Jardine, Alan.

Afiliación

Fellström B; Department of Medical Sciences, Renal Unit, Uppsala University Hospital, Uppsala, S-75185 Sweden. Electronic address: bengt.fellstrom@medsci.uu.se.
Barratt J; Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK; John Walls Renal Unit, Leicester General Hospital, Leicester, UK; Postgraduate Specialty School of Clinical Academic Training, Health Education East Midlands, Leicester, UK.
Flöge J; Medizinische Klinik II, RWTH Aachen Univeristy, Aachen, Germany.
Jardine A; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, Scotland; Glasgow Renal Transplant Unit, Queen Elizabeth Hospital, Glasgow, Scotland.

Lancet ; 390(10113): 2625-2626, 2017 12 16.

Article en En | MEDLINE | ID: mdl-29256402

Asunto(s)

Budesonida; Glomerulonefritis por IGA; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Budesonida / Glomerulonefritis por IGA Límite: Humans Idioma: En Revista: Lancet Año: 2017 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google